Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Jacob

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Cell Reports|August 17, 2022
Glycosphingolipids are mediators of cancer plasticity through independent signaling pathwaysCécile Cumin, Yen-Lin Huang, Charlotte Rossdam, et al.
Cell Reports|October 5, 2024
Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fateThorsten Schaefer, Nitish Mittal, Hui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2024
Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian CancerTereza Lanickova, Michal Hensler, Lenka Kasikova, et al.
Science Translational Medicine|November 2, 2022
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockadeMichal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer, et al.
Nature Communications|March 22, 2024
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancerLenka Kasikova, Jana Rakova, Michal Hensler, et al.
Nature Communications|April 17, 2026
NKG2A inhibition promotes NK cell-CD8<sup>+</sup> T cell interactions to improve anticancer immunity in ovarian carcinomaTereza Lanickova, Artemis Angelidou, Michal Hensler, et al.
Nature Communications|October 31, 2024
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.
Cancer Cell|January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Nature Medicine|August 1, 2025
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Nature Medicine|May 27, 2025
Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Cell Reports|August 17, 2022
Glycosphingolipids are mediators of cancer plasticity through independent signaling pathwaysCécile Cumin, Yen-Lin Huang, Charlotte Rossdam, et al.
Cell Reports|October 5, 2024
Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fateThorsten Schaefer, Nitish Mittal, Hui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2024
Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian CancerTereza Lanickova, Michal Hensler, Lenka Kasikova, et al.
Science Translational Medicine|November 2, 2022
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockadeMichal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer, et al.
Nature Communications|March 22, 2024
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancerLenka Kasikova, Jana Rakova, Michal Hensler, et al.
Nature Communications|April 17, 2026
NKG2A inhibition promotes NK cell-CD8<sup>+</sup> T cell interactions to improve anticancer immunity in ovarian carcinomaTereza Lanickova, Artemis Angelidou, Michal Hensler, et al.
Nature Communications|October 31, 2024
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.
Cancer Cell|January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Nature Medicine|August 1, 2025
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Nature Medicine|May 27, 2025
Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Pageof 7